Cogent Biosciences, Inc. (NASDAQ:COGT) Stock Has Average Target Price of $51.56 According to Analysts
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twelve brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating, eight have assigned a buy rating and one has […]
8 Oct 09:28 · The Markets Daily